One of our core mantras at Nanalyze is that if 95% of professional investment managers can’t beat a broad market benchmark, it’s highly, highly unlikely that an all-night session of LMGTFY will lead you to the next Microsoft or Google. Indeed, a recent study that looked at the performance of more than 64,000 global stocks […]
Have you ever noticed that you can go years without hearing a particular word or name, but then suddenly it keeps popping up in uncanny ways? Lately, for us, it’s been SAP (SAP). No, we’re not talking about saps, as in Fools, but the world’s third-largest software company by revenue. Software developed by the $100 […]
Last month, we wrote about TaskUs stock (TASK), which offers a way to invest in a little light human slavery digital offshoring services. But the company relies heavily on a Philippines-based workforce to power its software-as-a–service (SaaS) model. There are references to artificial intelligence and automation technologies, but cheap or crowdsourced labor isn’t exactly what […]
Here’s a question for all you ESG advocates out there. When you go through and run your numbers that show how “diverse” an organization is, do you classify the employees in emerging market centers as “Asian?” You should, because John in Mumbai and Rosie in Manila are indeed “Asians.” So, isn’t it a problem that […]
In a sign of the times: Alphabet, Google’s parent company, reported an 8% decline in quarterly profits for Q1-2022. Don’t worry: We don’t have to start a GoFundMe campaign or anything. The titan of the tech giants still had net profits of more than $16 billion on about $68 billion for the most recent quarter. […]
The old “John in Mumbai” joke heralds back to the days when Indian support desk agents were given Western-sounding names which didn’t manage to fool anyone. These days that slight accent you hear when calling a support desk is the twang of Tagalog, the predominant language spoken in the Philippines. We’ll just say what everyone […]
One disadvantage of having a living investment methodology is that as things change, you need to go back and revisit previous conclusions that may have changed. For example, we instituted a rule that prevents us from investing in any firm with a market cap of less than one billion dollars. That’s because the smaller a […]
We’ve been in the business of researching stocks for 20 years now and never cease to be amazed at the sorts of nefarious individuals walking freely. The ability to smell a rat comes from years of exposure to the odor. Usually, it’s just a hunch. Then you do some digging and find past lawsuits in […]
In numerous studies, psychologists have found that rewards of an uncertain magnitude and timing are more motivating than rewards that are certain and expected at fixed intervals. Think about how you might perceive that boring monthly salary vs. a stock options award at bonus time. This psychological phenomenon is what makes certain activities such as […]
Using artificial intelligence (AI) to optimize the drug discovery process is an AI healthcare thesis that’s probably one of the more appealing and least mature when it comes to how machine learning will change industries. While themes like robotic process automation (RPA) and AI chips are reaching maturity and reaping rewards, we’ve yet to see […]